Ładuje się......
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
Globally, group B Streptococcus (GBS) remains the leading cause of sepsis and meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at risk of transmitting GBS to their newborns has been effective in reducing, but not e...
Zapisane w:
| Wydane w: | F1000Res |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
F1000Research
2016
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070600/ https://ncbi.nlm.nih.gov/pubmed/27803803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.9363.1 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|